2013-10-04T09:51:26-05:00 2012-12-31 410746749 CLIFTONLARSONALLEN LLP 20 E THOMAS RD STE 2300 PHOENIX AZ 85012 990 2012-01-01 861024333 THE INTERNATIONAL GENOMICS CONSORTIUM INTE 6028507000 445 NORTH FIFTH STREET NO 300 PHOENIX AZ 85004 DAVID W NEAL CPA 6028507000 2013-10-01 1 PHIL MCCOLLUM P00129716 6022662248 2012 2016-02-24 21:20:13Z DR ROBERT PENNY 445 NORTH FIFTH STREET NO 300 PHOENIX AZ 85004 8101906 0 X WWW.INTEGEN.ORG X 2001 AZ THE MISSION OF IGC IS TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES BY RIGOROUSLY DEVELOPING AND APPLYING POST-GENOME SCIENCE TO ADVANCES IN HUMAN HEALTH. 5 2 63 3 0 0 1000000 1000000 8577607 6205232 7907 -6978 470805 893938 10056319 8092192 0 0 0 0 5682591 4424099 0 0 0 3623967 4129925 9306558 8554024 749761 -461832 6728467 5382848 2277551 1731269 4450916 3651579 X THE MISSION OF IGC IS TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES BY RIGOROUSLY DEVELOPING AND APPLYING POST-GENOME SCIENCE TO ADVANCES IN HUMAN HEALTH. 1 1 4392783 4335027 THE CANCER GENOME ATLAS/BIOSPECIMEN CORE RESOURCE-THE CANCER GENOME ATLAS (TCGA), JOINTLY SPONSORED BY THE NATIONAL CANCER INSTITUTE (NCI) AND THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE (NHGRI), IS A LARGE-SCALE GENOMICS PROJECT WITH THE AMBITIOUS GOAL OF CREATING AN "ATLAS" OF THE CANCER GENOME. IGC IS THE BIOSPECIMEN CORE RESOURCE (BCR) FOR TCGA AND SERVES AS A CENTRALIZED LABORATORY/REPOSITORY THAT REVIEWS AND PROCESSES ALL CANCER AND NORMAL TISSUE SAMPLES (BLOOD INCLUDED) AND THEIR ASSOCIATED CLINICAL DATA USING RIGOROUS STANDARD OPERATING PROCEDURES FOR TCGA RESEARCH NETWORK. ALL DATA COLLECTED IS POSTED TO A PUBLICLY ACCESSIBLE GOVERNMENT WEBSITE, FREE OF ANY INTELLECTUAL PROPERTY RESTRICTIONS. 1457843 1672104 THE CANCER GENOME ATLAS/TISSUE SOURCE SITE NETWORK-IN ADDITION TO ITS FUNCTION AS A BCR, IGC IS ESTABLISHING A NETWORK OF TISSUE SOURCE SITES CAPABLE OF DELIVERING HIGH QUALITY, CLINICALLY ANNOTATED CANCER TISSUE SAMPLES INTO THE TCGA PROJECT. THE INITIAL PHASE OF THE PROJECT CALLS FOR COLLECTION OF 8475 SAMPLES OF NUMEROUS CANCER TYPES. IGC IDENTIFIES AND CONTRACTS WITH CANCER CENTERS THROUGHOUT THE WORLD, TRAINS THE SITES IN ALL ASPECTS OF PATIENT CONSENT, TISSUE COLLECTION AND PRESERVATION, SHIPMENT AND FOLLOW UP COLLECTION OF CLINICAL DATA. 443169 412521 PARADIGM DIAGNOSTICS-PARADIGM'S RESEARCH BRINGS CUTTING EDGE DIAGNOSTICS AND BIOMARKER DRIVEN CLINICAL TRIALS TO THE BENEFIT OF CANCER PATIENTS. PARADIGM ATTEMPTS TO DEVELOP POTENTIAL THERAPIES BASED ON SPECIFIC CHARACTERIZATION OF THE PATIENT'S TUMOR, PERSONALIZING EACH PATIENT'S COURSE OF TREATMENT. 257254 82943 NATIONAL BIOMARKER DEVELOPMENT ALLIANCE-THE NATIONAL BIOMARKER DEVELOPMENT ALLIANCE (PREVIOUSLY REFERRED TO AS ARIZONA BIOSIGNATURES ALLIANCE) IS EXPLORING THE NEED FOR VALIDATING ASSAYS FOR BIOMARKERS FOR THE BIOSCIENCE INDUSTRY IN ACCORDANCE WITH U.S. FOOD AND DRUG ADMINISTRATION. THE AIM IS TO BRING PRECISION AND ROBUSTNESS TO DIAGNOSTICS USED IN CLINICAL TRIALS AND PATIENT TESTING AT HOSPITALS AND LABORATORIES AROUND THE WORLD.EXPRESSION PROJECT FOR ONCOLOGY (EXPO)-THE EXPO BIOSPECIMEN REPOSITORY IS ONE OF THE NATION'S FIRST PUBLIC REPOSITORIES FOR CANCER BIOSAMPLES, GENOMIC DATA AND CLINICAL OUTCOME INFORMATION. ALL DATA IS POSTED AT A PUBLICLY AVAILABLE WEBSITE, FREE OF INTELLECTUAL PROPERTY RESTRICTION. RESIDUAL TISSUE IS AVAILABLE FOR REDISTRIBUTION FOR QUALIFIED AND APPROVED RESEARCH STUDIES. 257254 82943 6551049 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 0 0 1 28 0 1 63 1 0 0 0 0 0 0 0 0 0 0 X 5 2 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 AZ X DAVID W NEAL CPA 6028507000 445 N 5TH STREET SUITE 300 PHOENIX AZ 85004 RICHARD MALLERY ESQ 0.50 X 0 0 0 RUSSELL RICHARDSON 0.50 X 0 0 0 ROBERT J PENNY MDPHD 40.00 X X 640551 0 45233 DAVID MALLERY 40.00 X X 338968 0 32507 ROBERT ARMKNECHT JR 0.50 X 0 0 0 DAVID W NEAL CPA 40.00 X 168204 0 23296 WILLIAM TROY SHELTON 40.00 X 159236 0 21024 JOSEPH PAULAUSKIS PHD 40.00 X 195356 0 30188 CANDACE SHELTON 40.00 X 151049 0 21291 ERIN CURLEY 40.00 X 139333 0 21075 JOHN MARK SHERMAN 40.00 X 132684 0 21408 KEN BURNETT 40.00 X 125216 0 6916 ERIC THOMPSON 40.00 X 123229 0 24724 SCOTT MORRIS 40.00 X 108664 0 12329 2282490 0 259991 11 0 1 0 SNELL & WILMER LLP ONE ARIZONA CENTER PHOENIX AZ 85004 LEGAL SERVICES 708956 1 1000000 1000000 CONTRACT REVENUE 541711 6090100 6090100 A/P SETTLEMENT 541711 115132 115132 6205232 2736 2736 596575 0 596575 596575 596575 9714 -9714 -9714 -9714 OTHER INCOME 900099 297363 297363 297363 8092192 6502595 0 589597 1826902 1644212 182690 2120220 1705396 414824 74705 63427 11278 111838 24616 87222 290434 151045 139389 820595 117961 702634 34263 34263 597974 597974 16123 645 15478 344406 154325 190081 39676 38776 900 873624 786262 87362 135494 123758 11736 31731 20137 11594 5781 5781 786914 729419 57495 50248 50248 LAB SUPPLIES AND CONSUM 393096 393096 8554024 6551049 2002975 0 1256247 1298450 1001178 1503884 1707235 1369730 1519395 761610 162143 177261 2874089 2690078 999439 184011 24291 24291 58539 63611 6728467 5382848 1792188 1434155 187337 172114 125000 298026 0 2277551 1731269 X 3066394 3281849 1384522 369730 4450916 3651579 6728467 5382848 -461832 -337505 0 X X 0 1 X 1 0 X SCOTTSDALE HEALTHCARE HOSPITALS SCOTTSDALE AZ RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2823934 2639923 184011 50155 50155 0 184011 8152661 30874 19881 50755 8101906 -9714 -9714 8092192 8952366 368379 9714 20249 398342 8554024 0 8554024 PART XI, LINE 2D - OTHER ADJUSTMENTS: ICG MANAGEMENT CORP REVENUES INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS 19,881. PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON SALE OF ASSET -9,714. PART XII, LINE 2D - OTHER ADJUSTMENTS: ICG MANAGEMENT CORP EXPENSES INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS 20,249. X X 1 1 X X X 0 0 0 0 0 0 0 0 0 ROBERT J PENNY MDPHD 637703 0 0 0 2848 0 10000 0 35233 0 685784 0 0 0 DAVID MALLERY 337902 0 0 0 1066 0 10000 0 22507 0 371475 0 0 0 DAVID W NEAL CPA 166298 0 0 0 1906 0 7014 0 16282 0 191500 0 0 0 WILLIAM TROY SHELTON 155210 0 3000 0 1026 0 0 0 21024 0 180260 0 0 0 JOSEPH PAULAUSKIS PHD 193024 0 0 0 2332 0 8021 0 22167 0 225544 0 0 0 CANDACE SHELTON 150278 0 106 0 665 0 6214 0 15077 0 172340 0 0 0 ERIN CURLEY 138752 0 0 0 581 0 5544 0 15531 0 160408 0 0 0 JOHN MARK SHERMAN 130693 0 0 0 1991 0 0 0 21408 0 154092 0 0 0 PART I, LINE 1B FROM THE BENEFIT OF FREQUENT FLYER MILES ROBERT PENNY, THE CEO, QUALIFIES FOR FIRST-CLASS UPGRADES AT MINIMAL OR NO COST. IN ADDITION, ROBERT PENNY WAS PROVIDED WITH A TEMPORARY HOUSING ALLOWANCE IN THE AMOUNT OF $12,500. NONE OF THESE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION. RICHARD MALLERY SERVES AS BOARD CHAIRMAN 708957 PARTNER IN LAW FIRM THAT PROVIDES LEGAL SERVICES TO IGC. 0 NEW PROGRAM SERVICES FORM 990, PART III, LINE 2 PARADIGM DIAGNOSTICS- PARADIGM'S RESEARCH BRINGS CUTTING EDGE DIAGNOSTICS AND BIOMARKER DRIVEN CLINICAL TRIALS TO THE BENEFIT OF CANCER PATIENTS. PARADIGM ATTEMPTS TO DEVELOP POTENTIAL THERAPIES BASED ON SPECIFIC CHARACTERIZATION OF THE PATIENT'S TUMOR, PERSONALIZING EACH PATIENT'S COURSE OF TREATMENT. CHANGES IN PROGRAM SERVICES FORM 990, PART III, LINE 3 NATIONAL BIOMARKER DEVELOPMENT ALLIANCE- THE NATIONAL BIOMARKER DEVELOPMENT ALLIANCE WAS PREVIOUSLY REFERRED TO AS ARIZONA BIOSIGNATURES ALLIANCE. FORM 990, PART VI, SECTION A, LINE 2 DAVID MALLERY HAS A FAMILY AND BUSINESS RELATIONSHIP WITH RICHARD MALLERY. RICHARD MALLERY (CHAIRMAN OF IGC'S BOARD OF DIRECTORS) AND DAVID MALLERY (PRESIDENT OF IGC) ARE FATHER AND SON. ROBERT PENNY AND DAVID MALLERY HAVE A BUSINESS RELATIONSHIP WITH SHELBY SCHARBACH. MARICOPA COUNTY HAS A MULTI-YEAR ECONOMIC FUNDING AGREEMENT WITH IGC, WHICH INCLUDES A PROVISION FOR A NON-VOTING OBSERVER TO BE IN ATTENDANCE AT IGC BOARD MEETINGS. SHELBY SCHARBACH, CFO FOR MARICOPA COUNTY, IS THE DESIGNATED OBSERVER. FORM 990, PART VI, SECTION A, LINE 8B THERE ARE NO COMMITTEES THAT HAVE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11 990 WILL BE REVIEWED BY THE CFO, AND THEN A DRAFT WILL BE PRESENTED TO THE BOARD BEFORE BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE POLICY REQUIRES THE DISCLOSURE OF ANY POTENTIAL CONFLICTS. ANY REPORTED CONFLICTS ARE REVIEWED BY UNINTERESTED MEMBERS OF THE BOARD OF DIRECTORS. THESE CONFLICTS ARE THEN MONITORED AND MANAGED BY THE PRESIDENT AND/OR CEO. IN ADDITION, IF A RELATED PARTY AGREEMENT IS PROPOSED, THE BOARD IS REQUIRED TO INVESTIGATE ALTERNATIVES BEFORE THEY WILL APPROVE SUCH AN AGREEMENT AS IN THE BEST INTERESTS OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15 LINE 15A, TOP MANAGEMENT OFFICIAL: IN 2011, COMPENSATION DATA WAS OBTAINED FROM SEVERAL COMPENSATION SURVEYS ON SIMILAR POSITIONS IN OTHER FOR-PROFIT AND NOT-FOR-PROFIT ORGANIZATIONS. EDUCATION, EXPERIENCE AND FAMILIARITY WITH IGC'S TARGETED CLIENTELE WERE THEN FACTORED INTO THE SUGGESTED COMPENSATION RANGES. FINAL COMPENSATION AMOUNTS WERE REVIEWED, APPROVED AND FORMALLY DOCUMENTED BY THE BOARD OF DIRECTORS. LINE 15B, OTHER OFFICERS AND KEY EMPLOYEES: IN 2011, COMPENSATION DATA WAS OBTAINED FROM SEVERAL COMPENSATION SUREVEYS ON SIMILAR POSITIONS IN OTHER FOR-PROFIT AND NOT-FOR-PROFIT ORGANIZATIONS. FINAL COMPENSATION WAS REVIEWED, APPROVED AND DOCUMENTED BY THE CEO, PRESIDENT AND CFO. FORM 990, PART VI, SECTION C, LINE 19 WE DO NOT MAKE OUR GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PAGE 12, PART XII, LINE 2C THERE HAS BEEN NO CHANGE IN THE PROCESS DURING THE CURRENT TAX YEAR. FORM 990, PAGE 5, QUESTIONS 7G AND H THE ORGANIZATION DID NOT RECEIVE THE TYPES OF CONTRIBUTIONS LISTED AND, THEREFORE, DOES NOT HAVE EITHER A FORM 8899 OR A FORM 1098-C FILING REQUIREMENT. THEREFORE, THESE QUESTIONS ARE LEFT BLANK BECAUSE THEY ARE NOT APPLICABLE AND THE ANSWER IS NEITHER YES OR NO. IGC MANAGEMENT SERVICES LLC 445 N 5TH ST SUITE 300 PHOENIX AZ 85004 800361103 INVESTMENT IN IGC MGMT CORPORATION AZ 24291 IGC IGC MANAGEMENT CORPORATION 445 N 5TH STREET SUITE 300 PHOENIX AZ 85004 453017176 BIOBANKING AZ IMS LLC C 19881 20490 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 IGC MANAGEMENT CORPORATION O 0